by Eric Christianson | Nov 10, 2019 | Drug Interaction Case Studies and Education For Pharmacists, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
Metformin is the go-to first-line medication in type 2 diabetes. While drug interactions aren’t incredibly common with its use, we should be aware of OCT inhibition and the potential effects that this might cause. Under normal circumstances, this isn’t...
by Eric Christianson | Oct 16, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
As you are reviewing a medication list, it can be easy to overlook supplements. The next time you review a medication list and you see sodium chloride supplements on the list, I want you to think of this post. If you have a patient who needs more sodium, they likely...
by Eric Christianson | Oct 2, 2019 | Medication and Disease State Clinical Pearls For Pharmacists, Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
A 68-year-old male presents to your care with chronic back pain. He is taking ketorolac and states that NSAIDs are the mainstay of pain relief. He won’t take opioids due to a family history of addiction. Acetaminophen and other medications he has tried in the...
by Eric Christianson | Sep 29, 2019 | Free Clinical Practice Quizzes and Videos For Pharmacists, Medication and Disease State Clinical Pearls For Pharmacists, Pharmacogenomics and Pharmacokinetics Medication and Disease State Clinical Pearls
We are adding a few new videos to our current content and am also updating numerous videos. Atrial fibrillation, asthma, COPD, Vaccines, Ulcerative Colitis, and Crohn’s are few of the many updates I’m working on for the 2020 release! The updates will be...
by Eric Christianson | Sep 25, 2019 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
The author has no conflicts of interest regarding oral semaglutide or any other diabetes medication. The GLP-1 agonists have been growing in popularity. The benefit of good A1C lowering effect coupled with the potential for weight loss are two of the main reasons why...
by Eric Christianson | Sep 11, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Clinical Pharmacy News and New Drug Updates, Medication and Disease State Clinical Pearls For Pharmacists
I’m a little bummed about my Minnesota Twins. Drug problems are everywhere and my team is not exempt. Apparently, hydrochlorothiazide is a drug of abuse in MLB’s drug testing policy. Mike Pineda, one of the Twins pitchers failed a drug test and was found...
